EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology

Seiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, Hidetaka Yamamoto, Shinji Sakurai, Hirotoshi Kikuchi, Tatsuo Kanda, Yukinori Kurokawa, Haruhiko Cho, Toshirou Nishida, Akira Sawaki, Masato Ozaka und 9 weitere

International Journal of Clinical Oncology · 2024-06 · 29 (6) · 647-680

DOI: 10.1007/s10147-024-02488-1 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 13.04.2024. Verfasst von Seiichi Hirota und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Japan. hiros@hyo-med.ac.jp. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Medical Oncology. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Labor Sciences Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Japan Society of Clinical Oncology Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) have been published in accordance with the Minds Manual for Guideline Development 2014 and 2017. A specialized team independent of the working group for the revision performed a systematic review. Since GIST is a rare type of tumor, clinical evidence is not sufficient to answer several clinical and background questions. Thus, in these guidelines, we considered that consensus among the experts who manage GIST, the balance between benefits and harms, patients’ wishes, medical economic perspective, etc. are important considerations in addition to the evidence. Although guidelines for the treatment of GIST have also been published by the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO), there are some differences between the treatments proposed in those guidelines and the treatments in the present guidelines because of the differences in health insurance systems among countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsMedical OncologyHumansJapanGastrointestinal NeoplasmsSocieties, MedicalEast Asian People

Stichwörter der Autor:innen

Clinical practice guidelinesExpert consensusGastrointestinal stromal tumor (GIST)Minds manual for guideline development

Autor:innen und Institutionen

  • Department of Surgical Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Japan. hiros@hyo-med.ac.jp.
  • Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Pathology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Diagnostic Pathology, Japan Community Healthcare Organization Gunma Central Hospital, Maebashi, Japan.
  • Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Förderung

  • Health and Labor Sciences Research Grant

Zitieren

APA

Hirota, S., Tateishi, U., Nakamoto, Y., Yamamoto, H., Sakurai, S., Kikuchi, H., Kanda, T., Kurokawa, Y., Cho, H., Nishida, T., Sawaki, A., Ozaka, M., Komatsu, Y., Naito, Y., Honma, Y., Takahashi, F., Hashimoto, H., Udo, M., Araki, M., …, & Members of the Systematic Review Team of the Present Guidelines (2024). English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology. International Journal of Clinical Oncology, 29(6), 647-680. https://doi.org/10.1007/s10147-024-02488-1

Vancouver

Hirota S, Tateishi U, Nakamoto Y, Yamamoto H, Sakurai S, Kikuchi H, et al. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology. International Journal of Clinical Oncology. 2024;29(6):647-680. doi:10.1007/s10147-024-02488-1

BibTeX
@article{Hirota2024,
  author = {Hirota, Seiichi and Tateishi, Ukihide and Nakamoto, Yuji and Yamamoto, Hidetaka and Sakurai, Shinji and Kikuchi, Hirotoshi and Kanda, Tatsuo and Kurokawa, Yukinori and Cho, Haruhiko and Nishida, Toshirou and Sawaki, Akira and Ozaka, Masato and Komatsu, Yoshito and Naito, Yoichi and Honma, Yoshitaka and Takahashi, Fumiaki and Hashimoto, Hironobu and Udo, Midori and Araki, Minako and Nishidate, Sumito and Members of the Systematic Review Team of the Present Guidelines, Members of the Systematic Review Team of the Present Guidelines},
  title = {English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  volume = {29},
  number = {6},
  pages = {647--680},
  doi = {10.1007/s10147-024-02488-1}
}
Kostenlos starten →